Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
LY-272,015
Другие языки:

    LY-272,015

    Подписчиков: 0, рейтинг: 0
    LY-272,015
    LY-272,015 structure.png
    Clinical data
    Other names LY-272,015; 1-[(3,4-Dimethoxyphenyl)methy]-2,3,4,9-tetrahydro-6-methyl-1H-pyrido[3,4-b]indole
    Identifiers
    • 1-(3,4-dimethoxybenzyl)-6-methyl-2,3,4,9-tetrahydro-1H-β-carboline
    CAS Number
    PubChem CID
    ChemSpider
    UNII
    CompTox Dashboard (EPA)
    Chemical and physical data
    Formula C21H24N2O2
    Molar mass 336.435 g·mol−1
    3D model (JSmol)
    • c4cc(C)cc3c4[nH]c2c3CCNC2Cc(cc1OC)ccc1OC
    • InChI=1S/C21H24N2O2/c1-13-4-6-17-16(10-13)15-8-9-22-18(21(15)23-17)11-14-5-7-19(24-2)20(12-14)25-3/h4-7,10,12,18,22-23H,8-9,11H2,1-3H3
    • Key:GDAJGLDMCDMPIR-UHFFFAOYSA-N
      (verify)

    LY-272,015 is a beta-carboline derivative drug developed by Eli Lilly, which acts as a potent and selective antagonist at the serotonin 5-HT2B receptor. It has anti-hypertensive effects in animal models, and is also used in research into the other functions of the 5-HT2B receptor.


    Новое сообщение